A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas
Clinical trial NCT05415072 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05415072
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-04
- Primary completion
- 2027-10-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.